We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft Guidance Standardizes Reporting of CM&S Studies
Draft Guidance Standardizes Reporting of CM&S Studies
The FDA has issued draft guidance standardizing the way companies report computational modeling and simulation studies, paving the way for more computer modeling in medical device trials.